Ad is loading...
MENU
RARE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Ultragenyx Pharmaceutical (RARE) Earnings Date & Reports

Industry: @Biotechnology
A.I. Advisor
published Earnings

RARE is expected to report earnings to -139 cents per share on February 13

Ultragenyx Pharmaceutical RARE Stock Earnings Reports
Q4'24
Est.
$-1.40
Q3'24
Beat
by $0.08
Q2'24
Beat
by $0.14
Q1'24
Missed
by $0.28
Q4'23
Beat
by $0.18
The last earnings report on November 05 showed earnings per share of -139 cents, beating the estimate of -148 cents. With 818.89K shares outstanding, the current market capitalization sits at 4.13B.
View a ticker or compare two or three
RARE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of therapeutics for rare diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
60 Leveroni Court
Phone
+1 415 483-8800
Employees
1276
Web
https://www.ultragenyx.com